We are live on ! Find out more
NNVC icon

NanoViricides

36 hedge funds and large institutions have $3.01M invested in NanoViricides in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

417% more call options, than puts

Call options by funds: $217K | Put options by funds: $42K

200% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 5

38% more funds holding

Funds holding: 2636 (+10)

1.05% less ownership

Funds ownership: 8.4%7.35% (-1%)

47% less capital invested

Capital invested by funds: $5.7M → $3.01M (-$2.69M)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
36
Holders Change
+10
Holders Change %
+38.46%
% of All Funds
0.73%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
3
Reduced
8
Closed
5
Calls
$217K
Puts
$42K
Net Calls
+$175K
Net Calls Change
+$175K

NNVC Hedge Fund Activity: Q3 2020 in Review

36 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2020, worth a combined $3.01M — down 47% from $5.7M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new NNVC positions and 5 closed out — a net gain of 10 holders — while 3 added to existing stakes and 8 trimmed.

The largest buyer was Wedbush Securities, opening a new position worth an estimated $260K. The largest seller was Bank of America, cutting an estimated $528K.

  • 36 institutional investors held NanoViricides (NNVC) as of Q3 2020, up from 26 in Q2 2020.
  • Funds reported $3.01M of NanoViricides stock for Q3 2020, down 47% quarter-over-quarter.
  • 15 funds opened new NanoViricides positions in Q3 2020 and 5 closed out, a net change of +10 holders.
  • The largest NanoViricides buyer in Q3 2020 was Wedbush Securities, an estimated $260K added.
  • The largest NanoViricides seller in Q3 2020 was Bank of America, an estimated $528K sold.

Based on aggregated 13F filings for Q3 2020.